Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Oct 13, 2026

AYTU — Aytu BioPharma, Inc. Dilution Risk Tracker

Track AYTU dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AYTU — Get alerts when the score changes →

As of October 13, 2026, Aytu BioPharma, Inc. (AYTU) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Aytu BioPharma, Inc. has a market capitalization of $22.01M, 10.87M shares outstanding, 38 institutional holders tracked. Stored dilution-related fields include 12.63M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
10
📊 Float Risk
45
⚠️ Warrant Exposure
90
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 116% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track AYTU — Get forecast alerts →

Market Data

Market Cap$22.01M
Shares Outstanding10.87M
Float7.61M
Cash$26.31M
Debt$10.03M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore37/100DilutionWatch score record
Shares Outstanding10.87MVerified float table or market cache
Public Float7.61MVerified float table or market cache
Market Cap$22.01MMarket data cache
Cash Runway28.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants12.63MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 9.9% shares (2026Q1 vs prior)
38 institutional holders · 4.21M shares
#1 Nantahala Capital Management, LLC 1.09M shares
#2 Stonepine Capital Management, LLC 792.3K shares
#3 AWM Investment Company, Inc. 619.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest345.2K
Days to Cover4.7
% of Float4.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-09-22
xbrl XBRL CONVERTIBLE 2022-09-27
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AYTU Dilution Snapshot

Aytu BioPharma, Inc. (AYTU) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AYTU's DilutionScore is currently 37/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 24/100 (Low risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202637/100MEDIUM13 days
Aug 22 – Sep 30, 202624/100LOW40 days
Aug 14 – Aug 21, 202631/100MEDIUM7 days
Jul 16 – Aug 13, 202624/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track AYTU Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AYTU files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AYTU — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AYTU
AYTU FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.